India tightens Regulations on Cough Syrups: A Move to Protect Public Health, Especially Children
Published: January 1, 2026 | Updated: January 1, 2026
The Indian government has proposed notable amendments to its drug regulations, signaling a proactive step towards bolstering public safety, particularly concerning the over-the-counter (OTC) sale of cough syrups. This move comes amidst growing global concerns regarding the safety and quality of pharmaceutical products, and follows recent tragic incidents linked to contaminated cough syrup. As a leading content strategist and SEO expert, I’ll break down what these changes mean, why they’re crucial, and what impact they’re likely to have on consumers and the healthcare landscape.
The Proposed Changes: Removing ‘Syrup’ from Schedule K
The Ministry of Health and Family Welfare recently issued a draft notification amending the Drugs Rules of 1945. The core of the proposed change involves removing the word “syrup” from Schedule K of these rules. While seemingly a minor alteration, this has substantial implications. Schedule K outlines drugs exempt from certain restrictions, allowing them to be sold without a prescription. By removing “syrup” from this list,the government effectively moves towards requiring a prescription for all cough syrups.
The official notification, published for public review and feedback (with a 30-day window for objections and suggestions), reads: “In the Drugs Rules, 1945, in Schedule K, in the Serial No. 13,under the column “‘Class of Drugs’,in the Entry no. 7, the word “Syrup,” shall be omitted.” This seemingly technical adjustment is a key component of a broader strategy to enhance drug safety and accountability.
Why the Change? A Response to Growing Concerns
This decision isn’t occurring in a vacuum. It’s a direct response to a series of alarming events that have highlighted the risks associated with unregulated access to cough syrups. Most recently, in October 2025, the World Health Organisation (WHO) issued a critical alert following multiple child deaths and severe adverse effects linked to Coldrif cough syrup, manufactured by Tamil Nadu-based Sresan Pharmaceuticals.This incident, and others like it, underscored the potential for contaminated or improperly formulated syrups to cause significant harm.
The issue extends beyond contamination. As Dr. Atul Kakar, Chairperson of Medicine at Sir Gangaram Hospital, explains, “Recently, the word syrup which contains many of these syrups which are cough syrup have been banned by the government and in the month of October we did see lots of deaths happening in children in Rajasthan and Madhya Pradesh because of the cough syrup because they contained some substance which were poisonous.” He further emphasizes the need for stricter control over all medications dispensed by pharmacies, not just syrups. “Also, I feel that the medicine should not be prescribed by the chemist and there should not be much excess of the drugs given by the chemist…the government should be very strict in cutting down the medicines which are given by the chemist themselves.”
The Impact on Patient Safety, Especially for Children
Experts overwhelmingly support the proposed changes. Dr. Vivek Jain, Senior Director & Unit Head, Paediatrics, at Fortis Hospital, shalimar Bagh, Delhi, articulates the benefits clearly: “Removing syrups from the OTC exemption list is a timely and much-needed step. Liquid formulations are widely used in children, but they are also the most commonly misused–often given without correct dosing, age-appropriate indication, or medical supervision. Making syrups prescription-only will help curb self-medication, prevent dosing errors, and reduce unnecessary exposure to antibiotics, cough suppressants, and steroids. Ultimately, this move strengthens patient safety, especially for children, who are far more vulnerable to medication misuse.”
This vulnerability is a critical point. Liquid formulations, while convenient, are prone to inaccurate dosing, particularly when administered by non-medical personnel. The move to prescription-only status ensures that a qualified healthcare professional assesses the patient’s condition, determines the appropriate medication and dosage, and provides crucial guidance on administration.
What Does This Mean for consumers?
* Increased Access to Healthcare: while it may seem inconvenient, requiring a prescription encourages a visit to a doctor, leading to a more accurate diagnosis and appropriate treatment plan.
* Reduced Self-Medication: The ease of purchasing cough syrups OTC frequently enough leads to self-diagnosis and treatment, which can be dangerous and delay proper medical care.
* Safer Medication Practices: Prescriptions ensure that medications are used correctly, minimizing the risk of adverse effects and drug interactions.
* Greater Accountability: the prescription process creates a record of medication use, enhancing traceability and accountability within the healthcare system
Related reading